The β-Thalassemias
- 8 July 1999
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (2) , 99-109
Abstract
In 1925, Thomas Cooley and Pearl Lee described a form of severe anemia, occurring in children of Italian origin and associated with splenomegaly and characteristic bone changes.1 Over the next decade, a milder form was described independently by several Italian investigators.24 Because all early cases were reported in children of Mediterranean origin, the disease was later termed thalassemia, from the Greek word for sea, thalassa.5 Over the next 20 years, it became apparent that Cooley and Lee had described the homozygous or compound heterozygous state for a recessive mendelian disorder not confined to the Mediterranean, but occurring widely . . .Keywords
This publication has 97 references indexed in Scilit:
- Hemoglobin E β-thalassemia: An increasingly common disease with some diagnostic pitfallsThe Journal of Pediatrics, 1998
- Evaluation of a new method of administration of the iron chelating agent deferoxamineThe Journal of Pediatrics, 1997
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Iron-Chelating TherapyCRC Critical Reviews in Clinical Laboratory Sciences, 1988
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982
- 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+ThalassemiaNew England Journal of Medicine, 1982
- Hereditary HemochromatosisNew England Journal of Medicine, 1979
- Iron in the heartThe American Journal of Medicine, 1971
- Mediterranean disease-thalassemia(Erythroblastic anemia of cooley)The Journal of Pediatrics, 1936